Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05787522 | Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk | completed | — | 500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06361056 | Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials | completed | N/A | 80 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 12, 2026 |
| clinicaltrials |
| NCT02212860 | Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy(SIGNAL 2) | completed | N/A | 139 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT02499146 | Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer | completed | Phase 1 | 26 | PfizerINDUSTRY | 1 | Feb 11, 2026 | clinicaltrials |
| NCT05810025 | FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments(FHIR) | completed | N/A | 70 | Columbia UniversityOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT05415215 | A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer(ProHer) | completed | Phase 3 | 346 | Hoffmann-La RocheINDUSTRY | 17 | Feb 10, 2026 | clinicaltrials |
| NCT06009627 | Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients | completed | Phase 2 / Phase 3 | 119 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT06267014 | Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity(Cog-RV) | completed | N/A | 23 | Centre Francois BaclesseOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT04361240 | Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study | completed | — | 172 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT00066703 | Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer(TEXT) | completed | Phase 3 | 2,672 | ETOP IBCSG Partners FoundationNETWORK | 17 | Feb 6, 2026 | clinicaltrials |
| NCT02520063 | Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer | completed | Phase 1 / Phase 2 | 15 | University of Alabama at BirminghamOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT03025035 | Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer | completed | Phase 2 | 14 | Yuan YuanOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT00893035 | Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients | completed | — | 885 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT01796197 | Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa | completed | Phase 2 | 23 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03981731 | Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session(COHEC) | completed | N/A | 53 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT04001751 | Feasibility Study: Yoga Educational Project(SKYPE) | completed | N/A | 24 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT04054557 | Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence | completed | N/A | 305 | Thomas Jefferson UniversityOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT05254678 | Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy(Empower) | completed | N/A | 32 | University of AlbertaOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT06830486 | Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)(ABIDE) | completed | — | 40 | University of Colorado, DenverOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07388238 | Ultrasound-Guided PEC I vs SAP Block for Postoperative Analgesia in Modified Radical Mastectomy(PECS I vs SAP) | completed | N/A | 32 | Ain Shams UniversityOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT04275661 | Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery | completed | Phase 2 | 60 | Assiut UniversityOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT05102500 | Second Opinions in Oncology | completed | — | 236 | University of Colorado, DenverOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT01881048 | Window of Opportunity Study Targeting the Inflammatory Milieu | completed | Early Phase 1 | 42 | University of Colorado, DenverOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT02759133 | Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire(IodineBreast) | completed | N/A | 350 | Centre Antoine LacassagneOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT02999477 | A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer | completed | Phase 1 | 32 | Adrienne G. WaksOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT04481113 | Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer | completed | Phase 1 | 8 | OHSU Knight Cancer InstituteOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT06203197 | The Effect of Mobile-Based Care and Monitoring on Lymphatic Edema Management and Quality of Life in Breast Surgery | completed | N/A | 60 | Sanko UniversityOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT00897702 | Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer | completed | — | 269 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05138510 | Sexual Health in Breast Cancer Patients | completed | — | 93 | University of Colorado, DenverOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT04640480 | Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors | completed | Phase 1 | 21 | SN BioScienceINDUSTRY | 1 | Jan 27, 2026 | clinicaltrials |
| NCT04991480 | A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors | completed | Phase 1 | 93 | Artios Pharma LtdINDUSTRY | 2 | Jan 27, 2026 | clinicaltrials |
| NCT06335108 | Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 ) | completed | — | 349 | University Hospital TuebingenOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT01494662 | HKI-272 for HER2-Positive Breast Cancer and Brain Metastases | completed | Phase 2 | 140 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT04913532 | Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer | completed | N/A | 35 | Capital Medical UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07363434 | A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With Ribociclib(RESONATE) | completed | — | 335 | Novartis PharmaceuticalsINDUSTRY | 1 | Jan 23, 2026 | clinicaltrials |
| NCT02158507 | Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer | completed | N/A | 20 | University of Alabama at BirminghamOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06499090 | Mirtazapine for Acute and Chronic Post Mastectomy Pain | completed | Early Phase 1 | 62 | Assiut UniversityOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06388304 | THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence(THRIVE) | completed | N/A | 39 | Joanna ArchOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT02086578 | Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant Reconstructions | completed | Phase 2 | 100 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT02668666 | Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer | completed | Phase 2 | 49 | Oana Danciu, MDOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT04319510 | Supportive Effects of Craniosacral Therapy for Women With Breast Cancer(CRANIO4US) | completed | N/A | 102 | Universität Duisburg-EssenOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT04763824 | KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice(KANSURVIVE) | completed | N/A | 15 | University of Kansas Medical CenterOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT06747065 | Polyurethan Versus Non-polyurethan Covered Implants in Combination With Radiotherapy(PRExRT) | completed | — | 1,000 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT07229560 | A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants | completed | Phase 1 | 16 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | Jan 14, 2026 | clinicaltrials |
| NCT03056755 | Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments(BYLieve) | completed | Phase 2 | 383 | Novartis PharmaceuticalsINDUSTRY | 19 | Jan 13, 2026 | clinicaltrials |
| NCT01413269 | Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery | completed | Phase 3 | 720 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT03685331 | HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer | completed | Phase 1 | 9 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT06771635 | Effect of Physical Training Program on the Exercise Adherence for Breast Cancer Survivor | completed | N/A | 62 | Universidad de BurgosOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT04864405 | Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance | completed | Phase 4 | 245 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 8, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Feb 12, 2026source: clinicaltrials